October 14, 2025

Purpose-built AI for pharmaceutical launches

See how to turn months of reporting into days with AI purpose-built for pharma.

Artificial intelligence (AI) has become ubiquitous, but the large language models we’re most familiar with – like ChatGPT and Google Assistant – are generic applications designed for generic tasks. Life science demands a purpose-built solution – one specifically designed for the needs of pharma companies, capable of handling sensitive data in a secure, compliant way and optimized to support go-to-market strategies. 

Within3’s Launch Intelligence Platform™ is that solution. Here’s what sets our proprietary AI apart.

Our AI in brief:

  • Reduces manual analysis and processing times by up to 90%
  • Reduces insight reporting times from months to days
  • Supports advisory boards to generate 7x more feedback than traditional engagements

Purpose-built for pharma

Our AI is designed specifically for the pharma industry, with compliance built in. We use unsupervised learning to cut through the noise of pharma industry data, empowering our customers to surface only the key topics that are truly relevant to their strategies. We never use customer data to train our AI systems, while all the data we do use is handled in compliance with relevant data protection laws and regulations – and anonymized and encrypted where appropriate.

Guardrails, governance, and ethics 

Our commitment to ethical and responsible AI begins at the design phase, where our AI systems are created with ethical standards and human rights at the top of mind. We apply stringent guardrails to our AI to eliminate ‘hallucinations’, minimize erroneous results, and monitor outputs for accuracy and relevance. Our dedicated AI governance team oversees the implementation of and adherence to our responsible AI policy, so any issues can be swiftly identified and addressed. 

Trust through transparency 

We endeavor to be as transparent as possible about how our AI systems are designed, and how they work. We maintain clear documentation to explain how our AI systems operate and how they come by their decisions, while confidence scores put a numerical value on the accuracy of those decisions. 

The unbiased truth 

We recognize that AI bias is often a reflection of programers’ unconscious biases. That’s why we use a panel of experts from highly diverse backgrounds to rank and score the data our sentiment models are trained on, so there’s no single point of view that decides what’s fair or accurate. Further, our AI models are thoroughly tested for bias and fairness before they’re deployed, with regular audits helping to identify and mitigate any unintended biases. 

Where ‘human’ meets AI 

Lastly, we put the human back in the loop as a final safeguard for our AI systems. We see human analysis as critical in cementing trust with our customers, and ensuring outcomes are as accurate and relevant as possible. This human oversight allows our models to be tweaked and adjusted to refine outputs and prevent drift.

The result? Deeper insights, better outcomes

The result of all these checks and safeguards is that Within3’s AI delivers superior outcomes for our users. Our secure, compliant, and ethical process helps to generate insights that align with our customers’ strategies – empowering teams to make faster, better-informed decisions pre-, peri-, and post-launch. 

We work hard to maintain these standards – our systems are designed to prioritize the user experience without compromising privacy or autonomy, while regular monitoring of performance metrics helps us recognize where our tools should be updated and improved.

Experience purpose-built life science AI for yourself.
Schedule a demo of our Launch Intelligence Platform™. 

Related Posts:

Metrics vs. Meaning: Rethinking How Pharma Measures Launch Success

A recap of key takeaways from “The Metrics, or the Truth?” — and how pharma teams can move beyond outdated KPIs to make smarter, more equitable launch decisions.
babble hypothesis

The babble hypothesis: quantity vs quality

How to manage bias in life science engagements to ensure every voice is heard.
video calls

More video calls…fewer insights?

Video conferencing is convenient but isn’t supporting your strategy. Here’s why.